Chứng hoại tử xương liên quan đến bisphosphonate gây thay đổi cấu trúc xương ổ răng ở chuột với sự tham gia của tín hiệu Wnt

Rachner TD, Platzbecker U, Felsenberg D, Hofbauer LC (2013) Osteonecrosis of the jaw after osteoporosis therapy with denosumab following long-term bisphosphonate therapy. Mayo Clin Proc 88:418–419 Ruggiero SL, Mehrotra B (2009) Bisphosphonate-related osteonecrosis of the jaw: diagnosis, prevention, and management. Annu Rev Med 60:85–96 Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O'Ryan F, Reid IR, Ruggiero SL, Taguchi A, Tetradis S, Watts NB, Brandi ML, Peters E, Guise T, Eastell R, Cheung AM, Morin SN, Masri B, Cooper C, Morgan SL, Obermayer-Pietsch B, Langdahl BL, al Dabagh R, Davison KS, Kendler DL, Sándor GK, Josse RG, Bhandari M, el Rabbany M, Pierroz DD, Sulimani R, Saunders DP, Brown JP, Compston J, on behalf of the International Task Force on Osteonecrosis of the Jaw (2015) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30:3–23 Li S, Li JJ (2019) Zoledronic acid modulates human osteosarcoma cells proliferation via GSK-3β activation. Neoplasma 66:766–775 Ikebe T (2013) Pathophysiology of BRONJ: drug-related osteoclastic disease of the jaw. Oral Sci Int 10:1–8 Watts NB, Marciani RD (2008) Osteonecrosis of the jaw. South Med J 101:160–165 Wat WZM (2016) Current controversies on the pathogenesis of medication-related osteonecrosis of the jaw. Dent J (Basel) 28:E38 Lian JB, Stein GS, Javed A et al (2009) Networks and hubs for the transcriptional control of osteoblastogenesis. Rev Endocr Metab Disord 7:1–16 Kawano Y, Kypta R (2003) Secreted antagonists of the Wnt signalling pathway. J Cell Sci 116:2627–2634 Dalcico R, de Menezes AM, Deocleciano OB et al (2013) Mechanisms of simvastatin in experimental periodontal disease. J Periodontol 84:1145–1157 Barba-Recreo P, Del Castillo Pardo de Vera JL, García-Arranz M, Yébenes L, Burgueño M (2014) Zoledronic acid - related osteonecrosis of the jaws. Experimental model with dental extractions in rats. J CranioMaxillofacial Surg 42:744–750 Maahs MP, Azambuja AA, Campos MM, Salum FG, Cherubini K (2011) Association between bisphosphonates and jaw osteonecrosis: a study in Wistar rats. Head Neck 33:199–207 Yanik S, Aras S, Erkılıç MH, Bozdağ Z, Demir T, Çetiner S (2016) Histopathological features of bisphosphonates related osteonecrosis of the jaw in rats with and without vitamin D supplementation. Arch Oral Biol 65:59–65 Jilka RL, Noble B, Weinstein RS (2013) Osteocyte apoptosis. Bone 54:264–271 Sousa LH, Linhares EV, Alexandre JT et al (2016) Effects of atorvastatin on periodontitis of rats subjected to glucocorticoid-induced osteoporosis. J Periodontol 87:1206–1216 Junqueira LC, Bignolas G, Brentani RR (1979) Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 11:447–455 Lima MR, Lopes AP, Martins C, Brito GAC, Carneiro VC, Goes P (2017) The effect of Calendula officinalis on oxidative stress and bone loss in experimental periodontitis. Front Physiol 8:1–9 Morris MD, Mandair GS (2011) Raman assessment of bone quality. Clin Orthop Relat Res 469:2160–2169 Aruwajoye OO, Kim HKW, Aswath PB (2015) Bone apatite composition of necrotic trabecular bone in the femoral head of immature piglets. Calcif Tissue Int 96:324–234 Sharma D, Hamlet S, Petcu E, Ivanovski S (2013) Animal models for bisphosphonate-related osteonecrosis of the jaws-an appraisal. Oral Dis 19:747–754 Curra C, Cardoso CL, Ferreira O et al (2016) Medication-related osteonecrosis of the jaw. Introduction of a new modified experimental model. Acta Cir Bras 31:308–313 Fedele S, Porter SR, D’Aiuto F et al (2010) Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series. Am J Med 123:1060–1064 Uda Y, Azab E, Sun N, Shi C, Pajevic PD (2017) Osteocyte Mechanobiology. Curr Osteoporos Rep 15:318–325 Allen MR (2009) Bisphosphonates and osteonecrosis of the jaw: moving from the bedside to the bench. Cells Tissues Organ 189:289–294 Reid IR, Cundy T (2009) Osteonecrosis of the jaw. Skelet Radiol 38:5–9 Koneski F, Popovic-Monevska D, Gjorgoski I, Krajoska J, Popovska M, Muratovska I, Velickovski B, Petrushevska G, Popovski V (2018) In vivo effects of geranylgeraniol on the development of bisphosphonate-related osteonecrosis of the jaws. J Craniomaxillofac Surg 46:230–236 George EL, Lin YL, Saunders MM (2018) Bisphosphonate-related osteonecrosis of the jaw: a mechanobiology perspective. Bone Rep 8:104–109 Xu X, Wen H, Hu Y, Yu H, Zhang Y, Chen C (2014) STAT1-caspase 3 pathway in the apoptotic process associated with steroid-induced necrosis of the femoral head. J Mol Histol 45:473–485 Carmagnola D, Canciani E, Sozzi D, Biglioli F, Moneghini L, Dellavia C (2013) Histological findings on jaw osteonecrosis associated with bisphosphonates (BONJ) or with radiotherapy (ORN) in humans. Acta Odontol Scand 71:1410–1417 Cuttle L, Nataatmadja M, Fraser JF, Kempf M, Kimble RM, Hayes MT (2005) Collagen in the scarless fetal skin wound: detection with picrosirius-polarization. Wound Repair Regen 13:198–204 Abou Neel EA, Aljabo A, Strange A, Ibrahim S, Coathup M, Young A, Bozec L, Mudera V (2016) Demineralization-remineralization dynamics in teeth and bone. Int J Nanomedicine 11:4743–4763 Rosset EM, Bradshaw AD (2016) SPARC/osteonectin in mineralized tissue. Matrix Biol 52:78–87 Rosset EM, Trombetta-eSilva J, Hepfer G, Yao H, Bradshaw AD (2017) SPARC and the N-propeptide of collagen I influence fibroblast proliferation and collagen assembly in the periodontal ligament. PLoS One 12:e0173209 Funayama H, Tashima I, Okada S, Ogawa T, Yagi H, Tada H, Wakita R, Asada Y, Endo Y (2019) Effects of zoledronate on local and systemic production of IL-1β, IL-18, and TNF-α in mice and augmentation by lipopolysaccharide. Biol Pharm Bull 42:929–936 Miao CG, Yang YY, He X, Li XF, Huang C, Huang Y, Zhang L, Lv XW, Jin Y, Li J (2013) Wnt signaling pathway in rheumatoid arthritis, with special emphasis on the different roles in synovial inflammation and bone remodeling. Cell Signal 25:2069–2078 Baron R, Kneissel M (2013) WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med 19:179–192 Xu Y, Sun J, Yang X, Yu Y, Mai H, Li Z (2017) Pamidronate disodium leads to bone necrosis via suppression of Wnt/β-catenin signaling in human bone marrow mesenchymal stem cells in vitro. J Oral Maxillofac Surg 75:2135–2143 Baron R, Rawadi G (2007) Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology 148:2635–2643 Tamanini S, Idolazzi L, Gatti D, Viapiana O, Fassio A, Rossini M (2013) Insight into the WNT system and its drug related response. Reumatismo 65:219–230 Yu Z, Fan L, Li J, Ge Z, Dang X, Wang K (2016) Lithium prevents rat steroid-related osteonecrosis of the femoral head by β-catenin activation. Endocrine 52:380–390 Ko JY, Wang FS, Wang CJ, Wong T, Chou WY, Tseng SL (2010) Increased Dickkopf-1 expression accelerates bone cell apoptosis in femoral head osteonecrosis. Bone 46:584–591. https://doi.org/10.1016/j.bone.2009.10.030 Rachner TD, Göbel A, Thiele S, Rauner M, Benad-Mehner P, Hadji P, Bauer T, Muders MH, Baretton GB, Jakob F, Ebert R, Bornhäuser M, Schem C, Hofbauer LC (2014) Dickkopf-1 is regulated by the mevalonate pathway in breast cancer. Breast Cancer Res 16:R20